Résultat de recherche

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 19/10/2020

Add to my selection

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 02/05/2020

Download document

Add to my selection

Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Health technology assessment - Posted on 11/02/2019

Download document

Add to my selection

Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Health technology assessment - Posted on 18/12/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of cysticercosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of trichinellosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of fasciolosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018

Download document

Add to my selection

Update of the Nomenclature of Laboratory Medicine Procedures for the diagnosis and monitoring of filariasis - INAHTA Brief

Health technology assessment - Posted on 16/04/2018

Download document

Add to my selection

Assessment of BCR-ABL fusion gene testing or quantification using RT-PCR in the diagnosis and therapeutic follow-up of chronic myeloid leukaemias and acute lymphoblastic leukaemias - INAHTA Brief

Health technology assessment - Posted on 13/11/2017

Download document

Add to my selection

Assessment of biological tests for Pneumocystis Pneumonia (Pneumocystis jirovecii infections) diagnosis - INAHTA Brief

Health technology assessment - Posted on 18/10/2017

Download document

Add to my selection

My account

You do not have a saved search

No element in selection

47 results

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of cysticercosis - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of trichinellosis - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of fasciolosis - INAHTA Brief

Update of the Nomenclature of Laboratory Medicine Procedures for the diagnosis and monitoring of filariasis - INAHTA Brief

Assessment of BCR-ABL fusion gene testing or quantification using RT-PCR in the diagnosis and therapeutic follow-up of chronic myeloid leukaemias and acute lymphoblastic leukaemias - INAHTA Brief

Assessment of biological tests for Pneumocystis Pneumonia (Pneumocystis jirovecii infections) diagnosis - INAHTA Brief

Follow us :